Analyst firms · Morgan Stanley · GLPG

Morgan Stanley GLPG price target and rating history

Galapagos NV (GLPG) · Health Care

Morgan Stanley rates Galapagos NV (GLPG) Underweight with a $22 price target, as of its latest action on Feb 14, 2025. It has published 5 rating actions on GLPG since January 2022, including 0 upgrades and 2 downgrades.

Current rating
Underweight
Price target
$22
Median target, all firms
Too few
Actions on GLPG
5

Morgan Stanley price target on GLPG

$80$51$222023202420252026
Morgan Stanley price target on GLPG, each point a stated target, January 2022 to February 2025.

Every Morgan Stanley rating on GLPG

Questions about Morgan Stanley and GLPG

What is Morgan Stanley's price target for GLPG?
Morgan Stanley's latest stated price target for Galapagos NV (GLPG) is $22, from its action on Feb 14, 2025.
What is Morgan Stanley's rating on GLPG?
Morgan Stanley rates GLPG Underweight, a bearish rating, as of Feb 14, 2025.
When did Morgan Stanley last change its view on GLPG?
On Feb 14, 2025, Morgan Stanley downgrades to Underweight from Equal-Weight, price target $31 to $22.

More GLPG rating histories

All Morgan Stanley ratingsGLPG news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.